By Tomas J. Philipson
July 19, 2024
As President Biden works to shore up support before the election and after a difficult first debate his administration is hastening to finalize a major proposal designed to address high drug prices.
Unfortunately, the administration’s proposal will do little to lower drug costs — while doing grave long-term damage to American patients.
Read the full article here.